FDA NDC Directory · JSON-LD · Markdown
NDC 88051-003 · DRUG FOR FURTHER PROCESSING · LIQUID
| Labeler / Manufacturer | Regenerative Cell Research Institute Private Ltd. |
|---|---|
| Marketing category | DRUG FOR FURTHER PROCESSING |
| Dosage form / route | LIQUID |
| Active ingredients | ALLOGENEIC HUMAN PLACENTA-DERIVED MESENCHYMAL STEM CELLS (1 mg/mL) |
| Marketing started | 20261016 |
| Package count | 3 |
Source: openFDA. Public-domain (CC0).